Rescuing "helpless" CD8+T cell Memory Responses by Activating NK Receptor NKG2D during Priming

被引：0
|
作者：
Guevara, Jose Alejandro [1 ]
Lyons, Gretchen Eiben [1 ]
McCracken, James [1 ]
O'Sullivan, Jeremy [1 ]
机构：
[1] Univ Chicago, Comm Immunol, Chicago, IL 60637 USA
来源：
FASEB JOURNAL | 2008年 / 22卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Significant role of the activating NK cell receptor NKG2D in cancer-linked to inflammation
    Sheppard, S.
    Guedes, J.
    Mroz, A.
    Goldin, R.
    Guerra, N.
    IMMUNOLOGY, 2013, 140 : 90 - 90
  • [22] IL-21 down-regulates NKG2D expression and function in human NK cells and differentially regulates NKG2D and CD28 expression on CD8+T cells
    Burgess, Steven James
    Marusina, Alina
    Borrego, Francisco
    Coligan, John
    JOURNAL OF IMMUNOLOGY, 2006, 176 : S27 - S27
  • [23] Pseudorabies Virus Infection Causes Downregulation of Ligands for the Activating NK Cell Receptor NKG2D
    Denaeghel, Sofie
    De Pelsmaeker, Steffi
    Van Waesberghe, Cliff
    Favoreel, Herman W.
    VIRUSES-BASEL, 2021, 13 (02):
  • [24] IL-2促进PBMC来源的NK、NKT、CD8+T细胞高表达NKG2D
    邬鹏
    魏海明
    田志刚
    中华微生物学和免疫学杂志, 2006, (08) : 684 - 687
  • [25] Studying the antagonistic relationship between NKG2D and TGF-β in CD8+T cells
    Prajapati, Kushal
    Guevara-Patino, Jose
    JOURNAL OF IMMUNOLOGY, 2015, 194
  • [26] Low expression of CD161 and NKG2D activating NK receptor is associated with impaired NK cell cytotoxicity in metastatic melanoma patients
    Gordana Konjević
    Katarina Mirjačić Martinović
    Ana Vuletić
    Viktor Jović
    Vladimir Jurisić
    Nada Babović
    Ivan Spužić
    Clinical & Experimental Metastasis, 2007, 24 : 1 - 11
  • [27] Low expression of CD161 and NKG2D activating NK receptor is associated with impaired NK cell cytotoxicity in metastatic melanoma patients
    Konjevic, Gordana
    Martinovic, Katarina Mirjacic
    Vuletic, Ana
    Jovic, Viktor
    Jurisic, Vladimir
    Babovic, Nada
    Spuzic, Ivan
    CLINICAL & EXPERIMENTAL METASTASIS, 2007, 24 (01) : 1 - 11
  • [28] NKG2D in NK and T cell-mediated immunity
    Ogasawara, K
    Lanier, LL
    JOURNAL OF CLINICAL IMMUNOLOGY, 2005, 25 (06) : 534 - 540
  • [29] NKG2D in NK and T Cell-Mediated Immunity
    Kouetsu Ogasawara
    Lewis L. Lanier
    Journal of Clinical Immunology, 2005, 25 : 534 - 540
  • [30] NKG2D receptor activation of mTOR and NFκB enhances antitumor immunity in effector CD8+T cells
    Whitman, Emily
    Barber, Amorette E.
    CANCER RESEARCH, 2014, 74 (19)
12345